Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial.

Choi KM, Han KA, Ahn HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Yoo HJ, Baik SH, Choi DS, Min KW.

J Clin Endocrinol Metab. 2012 Oct;97(10):3751-8. doi: 10.1210/jc.2012-1951. Epub 2012 Jul 26.

PMID:
22837190
2.

Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.

Davis KE, Prasad C, Vijayagopal P, Juma S, Imrhan V.

Nutr Res. 2014 Jun;34(6):478-85. doi: 10.1016/j.nutres.2014.04.012. Epub 2014 Apr 24.

PMID:
25026914
3.

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.

Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL.

Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):129-34. doi: 10.1016/j.numecd.2008.03.004. Epub 2008 Jul 2.

PMID:
18595673
4.

Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.

Tam LS, Shang Q, Li EK, Wong S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM.

Semin Arthritis Rheum. 2013 Feb;42(4):333-45. doi: 10.1016/j.semarthrit.2012.07.002. Epub 2012 Aug 22.

PMID:
22920235
5.

Physical activity is associated with risk factors for chronic disease across adult women's life cycle.

Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA.

J Am Diet Assoc. 2008 Jun;108(6):948-59. doi: 10.1016/j.jada.2008.03.015.

PMID:
18502225
6.

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.

Isoyama N, Leurs P, Qureshi AR, Bruchfeld A, Anderstam B, Heimburger O, Bárány P, Stenvinkel P, Lindholm B.

Nephrol Dial Transplant. 2015 Jan;30(1):84-91. doi: 10.1093/ndt/gfu259. Epub 2014 Jul 28.

PMID:
25074436
7.

Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.

Kadoglou NP, Iliadis F, Angelopoulou N, Sailer N, Fotiadis G, Voliotis K, Vitta I, Liapis CD, Alevizos M.

J Diabetes Complications. 2009 May-Jun;23(3):160-6. doi: 10.1016/j.jdiacomp.2007.12.008. Epub 2008 Apr 16.

PMID:
18413173
8.

The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with type 2 diabetes.

Kadoglou NP, Fotiadis G, Kapelouzou A, Kostakis A, Liapis CD, Vrabas IS.

Diabet Med. 2013 Feb;30(2):e41-50. doi: 10.1111/dme.12055.

PMID:
23078531
9.

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, Natali A, Ferrannini E, Gastaldelli A.

J Clin Endocrinol Metab. 2006 Nov;91(11):4628-34. Epub 2006 Aug 22.

PMID:
16926247
10.

Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.

Aubert CE, Michel PL, Gillery P, Jaisson S, Fonfrede M, Morel F, Hartemann A, Bourron O.

Diabetes Metab Res Rev. 2014 Nov;30(8):679-85. doi: 10.1002/dmrr.2529.

PMID:
24449227
11.

Soluble receptor for advanced glycation end products independently predicts cardiometabolic syndrome in Latino youth.

Brickey SR, Ryder JR, McClellan DR, Shaibi GQ.

Pediatr Diabetes. 2014 Sep;15(6):403-7. doi: 10.1111/pedi.12095. Epub 2013 Dec 9.

PMID:
24320614
13.

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.

Microvasc Res. 2008 May;76(1):52-6. doi: 10.1016/j.mvr.2007.09.004. Epub 2007 Oct 5.

PMID:
18474381
14.
15.

The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial.

Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, Solomon TP.

Diabetes Care. 2013 Feb;36(2):228-36. doi: 10.2337/dc12-0658. Epub 2012 Sep 21.

16.

Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients.

Oz Gul O, Tuncel E, Yilmaz Y, Ulukaya E, Gul CB, Kiyici S, Oral AY, Guclu M, Ersoy C, Imamoglu S.

Metabolism. 2010 Jan;59(1):64-9. doi: 10.1016/j.metabol.2009.07.006. Epub 2009 Aug 26.

PMID:
19709689
17.

The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.

Brix JM, Höllerl F, Kopp HP, Schernthaner GH, Schernthaner G.

Int J Obes (Lond). 2012 Nov;36(11):1412-7. doi: 10.1038/ijo.2012.107. Epub 2012 Jul 17.

PMID:
22828946
18.

Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.

Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD.

Diabetes. 2010 Aug;59(8):2027-32. doi: 10.2337/db09-1509. Epub 2010 Jun 3.

19.

Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial.

Laaksonen DE, Atalay M, Niskanen LK, Mustonen J, Sen CK, Lakka TA, Uusitupa MI.

Med Sci Sports Exerc. 2000 Sep;32(9):1541-8.

PMID:
10994902
20.

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.

Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ, Tan KC.

Clin Sci (Lond). 2011 Jan;120(2):81-9. doi: 10.1042/CS20100256.

PMID:
20726839

Supplemental Content

Support Center